Skip to main content
Publish date:

Paying Attention to Those Men Behind the Curtain

With 28 IPOs in the queue this week, Ben's keeping his eye on the smart money.

Take a second to scroll through the lineup for this week and marvel at the sheer number of deals that are slated to price. I just finished the table and I am astonished myself. Twenty-eight IPOs in one week, that's a lot of deals. But, this market seems more than willing to buy whatever volume of product the syndicate departments can turn out.

While I was preparing this week's list I found myself really drilling down on a particular part of the filings, a section that is usually titled


. This is where they list most of the large beneficial owners of a company's stock. It is here that you find out who


believes in these companies as investments. I always read these listings, but this week they just seemed far more telling than usual. This week they seemed packed with what I and many others refer to as

Smart Money

. In many of my comments I've included a listing of these shareholders. Take note of the names, and in time you'll begin to recognize them. The involvement of these

TheStreet Recommends


-investors can be an easy clue-in to the hot deals.

IPOs: Join the discussion on


message boards.

Of course, only after the deals are priced and the trading has begun can we tell just how smart these people really are.

Let's dig in and take a look at this week's deals:

Ben Holmes is the founder of, a Boulder, Colo.-based research boutique (now a wholly-owned subsidiary of specializing in the analysis of equity syndicate offerings. This column is not meant as investment advice; it is instead meant to provide insight into the methods of new and secondary offerings. Neither Holmes nor his firm has entered indications of interest in any of the companies discussed in this column. Holmes' This Week in IPOs column appears Sundays, This Week's Secondaries appears Tuesdays, Upcoming Lockup Expirations appears Wednesdays and The Quiet Period appears on Fridays. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Holmes appreciates your feedback at